Epistaxis (Nosebleeds) Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Timolol Gel for Epistaxis in Hereditary Hemorrhagic Telangiectasia
Condition: Hereditary Hemorrhagic Telangiectasia Interventions: Drug: Timolol Gel; Drug: Placebo Gel Sponsors: Washington University School of Medicine; Institute of Clinical and Translational Sciences (ICTS) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 25, 2019 Category: Research Source Type: clinical trials
Propranolol for Epistaxis in Hereditary Hemorrhagic Telangiectasia Patients
Conditions: Hereditary Hemorrhagic Telangiectasia; Osler Weber Rendu Disease Interventions: Drug: Propranolol treatment; Drug: Placebo Sponsors: University Hospital, Bordeaux; AMRO-HHT-France - Association Maladie de Rendu-Osler Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 2, 2019 Category: Research Source Type: clinical trials
